版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
November2026
McKinseyHealthInstitute
Beyonddelivery:The
humanandeconomictollofpreeclampsiaintheUS
Preeclampsiaaffectsaboutonein11birthsayearintheUnitedStates,
causingcomplicationsformothersandbabiesandcontributingto$28billionincosts.Moreinnovationandinvestmentcouldhelp.
Ataglance
—AnalysisofcommercialandMedicaidclaimsdataandpublishedliteraturesuggeststhatintheUnitedStatesalone,preeclampsiaaffectsanestimated325,000birthsannually,
contributestoseverematernalmorbidity,isassociatedwith1,000to2,200stillbirths,andislinkedtoover$28billionincostsoverthelifetimeofwomenwhodeveloppreeclampsia
everyyearandtheirchildren.
—Unlikemanyothercostlymedicalconditions,costsofpreeclampsiaarehighlyconcentratedandlikelyaddressable.Whilelifetimecostsaccountforasubstantialmajorityofthetotal
economicburden,approximatelyone-thirdofcostsareincurredarounddeliveryandthefirstyearpostpartumandarelargelydrivenbymaternalhospitalizationandneonatalintensive
care.
—Despitepreeclampsia’slargeburdenandunmetneed,thesolutionisoftendeliveringthe
baby,evenwhentheyarenotfullterm.Deliveryisthedefinitiveinterventionwhenmaternalorfetalrisksoutweighthebenefitsofcontinuingpregnancy.Improvementsinhealthaccessandcareusingexistingtools,aswellthedevelopmentofnew,effectivedisease-modifyingtherapies,couldimprovematernalandneonataloutcomesandreducehealthcarecosts.
Preeclampsiaisamultisystempregnancydisorderthattakesaheavytollonwomen’shealthintheUnitedStatesandaroundtheworld.1Itisassociatedwithnew-onsethypertensionafter
20weeks’gestation,thepresenceofexcessproteinintheurine,and/ormaternalorganor
placentaldysfunction.Itcanleadtoseverecomplications,includingdeath,formothersand
babies—especiallyformothersinlow-andmiddle-incomecountriesandBlackwomeninthe
UnitedStates.2Itseffectscanalsolastlongafterpregnancy:Womenwhohavehad
preeclampsiaandtheirchildrenfacehigherlong-termhealthrisks,particularlyofheartand
metabolicconditions.Severalstudieshaveestimatedthatwomenwithahistoryofpreeclampsiaexperienceatwotofourtimesincreasedriskofcardiovasculardisease.3
Preeclampsiahasgenerallybeenreportedtoaffectbetween5and8percentofpregnanciesintheUnitedStatesannually.AnewanalysisfromtheMcKinseyHealthInstituteconductedin
collaborationwiththeGatesFoundationhasfoundthatpreeclampsiaaffectsapproximatelyonein11livebirthsayear,or325,000of3.6millionannualbirths.4
1“Gestationalhypertensionandpreeclampsia:ACOGPracticeBulletin,number222,”Obstetrics&Gynecology,June2020.
Preeclampsiaresultsfromabnormalplacentaldevelopmentorotherriskfactorsthatrestrictbloodsupplytothefetus.Forthe
baby,thisreducesoxygenandnutrientsneededforhealthygrowth,increasingtheriskoffetalgrowthrestriction,pretermbirth
andothercomplications.Forthemother,thestresstotheplacentaresultsinreleaseofinflammatoryandanti-angiogenicproteinsintothebloodstream,whichcandamagebloodvessels,raisebloodpressure,andstrainmajororgans.Formore,seeK.KanasakiandR.Kalluri,“Thebiologyofpreeclampsia,”KidneyInternational,October2009.
2LeliaDuley,“Theglobalimpactofpre-eclampsiaandeclampsia,”SeminarsinPerinatology,June2009,Volume33,Number3;H.
O.Fasanyaetal.,“Acriticalreviewontheuseofraceinunderstandingracialdisparitiesinpreeclampsia,”JournalofAppliedLaboratoryMedicine,January2021,Volume6,Number1.
3LeanneBellamyetal.,“Pre-eclampsiaandriskofcardiovasculardiseaseandcancerinlaterlife:Systematicreviewandmeta-
analysis,”BMJ,November2007,Volume335,Number7627;LydiaJ.Leonetal.,“PreeclampsiaandcardiovasculardiseaseinalargeUKpregnancycohortoflinkedelectronichealthrecords:ACALIBERstudy,”Circulation,September24,2019,Volume140,Number13;GaiaBianchietal.,“Thedilemmaofchronickidneydiseaseandend-stagekidneydiseasefollowingpre-eclampsia:Aliteraturereviewandmeta-analysis,”InternationalUrologyandNephrology,December2025,Volume57,Number12;Pensee
Wuetal.,“Pre-eclampsiaisassociatedwithatwofoldincreaseindiabetes:Asystematicreviewandmeta-analysis,”Diabetologia,December2016,Volume59,Number12.
4The9percentfigureistakenfromGatesFoundationandMHIanalysisusingMerativeMarketScanCommercialclaimsdata
(2018–25)andCentersforMedicare&MedicaidServices,100percentMedicaiddata(2021–24)andappliedtothe3.6million
birthsintheUnitedStatesin2025.B.E.Hamilton,M.J.K.Osterman,andE.C.W.Gregory,Births:Provisionaldatafor2025,VitalStatisticsRapidReleaseReportNo.43,NationalCenterforHealthStatistics,April2026.
Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS2
Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS3
Everyyear,accordingtoouranalysisofcommercialandMedicaidclaims,preeclampsia’sdiseaseburdendrivesmorethan$28billioninlifetimeeconomicburdenforwomenwhodevelop
preeclampsiaintheUnitedStatesandfortheirchildren.5Whiletheseestimatesarefocusedontheimpactofpreeclampsiaonwomenandtheirchildren,thetrueburdenislikelygreater,as
preeclampsiaalsoaffectspartners,caregivers,andfamiliesmorebroadly.Approximately29
percent($8billion)ofcostsaremedicalcostsincurredbythehealthcaresystemwithinayearofdelivery.Theremainingcostsincludeanestimated$16billionto$18billionoflong-termmedicalcostsassociatedwithincreasedriskofchronicmaternalandchildhealthconditionsand
approximately$2billionto$3billioninsocietalcosts.Thehealthcareandeconomicburdenisparticularlyconcentratedamongwomenwithearly-onsetpreeclampsia(diagnosedearlierthan34weeksintopregnancy).Early-onsetdiseasemakesupapproximately20percentof
preeclampsiacases,butitaccountsforabout77percentofestimatedshort-termmedicalcostsamongaffectedbirthswithinoneyearofadmissionfordelivery.6
Despitethesehumanandeconomiccosts,thereiscurrentlynoapproveddisease-modifying
therapyforpreeclampsia.AsoutlinedintheWorldHealthOrganization’sGlobalroadmapfor
hypertensivedisordersofpregnancyfrom2026to2035,thedevelopmentofpreeclampsia
therapeuticshasnotbeensufficienttoaddresstheneed,withonlyahandfulofcandidatesin
activeclinicaldevelopment.7Barrierstodevelopmentoftherapeuticsincludeconcernsabout
liabilityformaternalandfetalsafetyduringtrials,relativelyuntestedregulatorypathwaysfor
novelmechanisms,andlackofcoordinationacrossresearchers,innovators,andpolicy-makers.8Thedevelopmentofnewtherapeuticsthatpreventorslowdiseaseprogression,alongside
improvementsinriskidentification,antenatalmanagement,andpostpartumfollow-up,could
improvematernalandneonataloutcomesandreducetheburdenassociatedwiththecondition.
ThisanalysiscomplementsMHI’srecentCAREforWomenreport,whichhighlightedgapsin
caredeliveryforpregnancyandcardiovasculardisease,includinghypertensivedisorders.ItalsobuildsonMHI’s2025reportBlueprinttoclosethewomen’shealthgap,whichfoundthat
closingthegapontreatmentformaternalhypertensivedisordersrepresentspotentialestimatedgainsof0.85millionannualdisability-adjustedlifeyears(DALYs).
Thispaperfocusesonopportunitiesforinnovatorsandinvestorstogeneratenewapproachestopreeclampsiapreventionandtreatment,basedonthehumanandeconomicburdenof
preeclampsia.Whileitoutlinessomeopportunitiestoimprovecaredeliverywithexistinginterventions,thisisnotaprimaryfocusofthepaper.
pidReport.Ap
5GatesFoundationandMHIanalysisusingMerativeMarketScanCommercialclaimsdata(2018-2025);CentersforMedicare&
MedicaidServices,100percentMedicaiddata(2021–24),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeensuppressed).CertaindatausedinthisstudyweresuppliedbyMerativeaspartofoneormoreMerativeMarketScanResearchdatabases.Anyanalysis,interpretation,orconclusionbasedonthesedataissolelythatofthe
authorsandnotMerative.
6GatesFoundationandMHIanalysisfoundthatamongUSbirths,9percentofmotherswillbediagnosedwithpreeclampsia,whichisinclusiveofthe2percentofmotherswhohaveearly-onsetpreeclampsia.
7Globalroadmapforhypertensivedisordersofpregnancyfrom2026to2035andbeyond,WorldHealthOrganization,October
2026;“Preeclampsiaandfetalgrowthrestriction,”DiaMedicaTherapeutics,accessedOctober2026;GunvorEkman-Ordebergetal.,“Tafoxiparin,anoveldrugcandidateforcervicalripeningandlaboraugmentation:Resultsfrom2randomized,placebo-
controlledstudies,”AmericanJournalofObstetricsandGynecology,March2024,Volume230,Number3S;“AmoytopBiotech’spegfilgrastimgainsNMPAapprovalforpreeclampsiaclinicaltrials,”FinelineCube,January7,2025;“AphaseI,randomized,
cross-over,single-center,single-dosefastedstudyofEG-101IVinjection(EG-ZNMP-01)inhealthyvolunteerstoserveasa
safetylead-infordosinginpregnantwomenwithseverepre-eclampsia,”NCT07327255,ClinicalT,accessedOctober
2026;“Anopen-label,dosefindingstudytoevaluatethesafety,tolerability,pharmacokinetics,andpharmacodynamicsofsingleascendingsubcutaneousdosesofCBP-4888inhospitalizedparticipantswithpretermpreeclampsiareceivingstandardofcare,expectantmanagement,”NCT07282171,ClinicalT,accessedOctober2026.
8Globalroadmapforhypertensivedisordersofpregnancyfrom2026to2035andbeyond,WorldHealthOrganization,October2026.
Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS4
Prevalenceandeffectsofpreeclampsia
MHIanalysisofUScommercialandMedicaidclaimsfoundthatapproximately9percentof
pregnancyepisodesprecedinglivebirthsmetthestudydefinitionofpreeclampsia,
correspondingtoroughly325,000birthsannuallywhenappliedtotheUSbirthpopulation.9(Formore,seesidebar,“Methodology.”)Preeclampsiaisassociatedwithmaternalmortalityand
seriousmaternalcomplications,includingacutekidneyinjury,HELLPsyndrome,stroke,andplacentalabruption,anditincreasestherisksoffetalgrowthrestriction,medicallyindicatedpretermdelivery,andstillbirth.10
ThisreportfocusesonpreeclampsiaintheUnitedStatesspecifically,becauseoftheavailabilityofclaimsdata,butpreeclampsiaisaworldwideissue.11Preeclampsiaandresultingeclampsiaarealeadingcauseofmaternalmorbidityandmaternalmortalityglobally(hypertensivedisorders
causeanestimated42,000maternaldeaths12and500,000infantdeathsannually13)andisoneofthetopsixcausesofmaternalmortalityintheUnitedStates.14IntheUnitedStatesalone,
preeclampsialeadsto1,000to2,200stillbirthseveryyear.15
Inanycountry,establishedriskfactorsforpreeclampsiaincludetype1ortype2diabetes,
previoushypertension,obesity,familyhistoryofpreeclampsia(includingpartner’sgeneticsandfamilyhistory),16priorpreeclampsia,firstpregnancy,andextremesofmaternalage.17Inthe
UnitedStates,theprevalenceofsomeoftheseriskfactorshasincreasedsubstantially:From2010to2021,ratesofchronichypertensionincreasedfrom1.2percentto2.7percent,ratesofpregestationaldiabetesincreasedfrom0.7percentto1.1percent,ratesofwomenhavingtheirfirstchildatage35orolderincreasedfrom14.7percentto20.1percent,andratesofobesityincreasedfrom22.5percentto30.5percent.18
Forthisanalysis,preeclampsiaisgroupedintothreetiming-basedcategories:early-onset,late-onset,andpostpartumpreeclampsia(Exhibit1).
—Early-onsetpreeclampsia,occurringbefore34weeksofgestation,19isoftenlinkedto
9PrevalenceofpreeclampsiainMedicaidandcommercialdatasetsis9percent.MerativeMarketScanCommercialclaimsdata(2018–25);CentersforMedicare&MedicaidServices,100percentMedicaiddata(2021–24),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeensuppressed).CertaindatausedinthisstudyweresuppliedbyMerativeaspartofoneormoreMerativeMarketScanResearchDatabases.Anyanalysis,interpretation,or
conclusionbasedonthesedataissolelythatoftheauthorsandnotMerative.
10HELLP(hemolysis,elevatedliverenzymes,lowplateletcount)isarareformofpreeclampsia.Formore,see“HELLPsyndrome,”ClevelandClinic,lastupdatedMarch27,2024;SaroshRanaetal.,“Preeclampsia:Pathophysiology,challenges,and
perspectives,”CirculationResearch,March29,2019,Volume124;MisganawFikrieMelesseetal.,“MaternaloutcomesofseverepreeclampsiaandeclampsiaandassociatedfactorsamongwomenadmittedatreferralhospitalsofAmhararegionalstate,
institutional-basedcross-sectionalstudy,North-WestEthiopia,”FrontiersinGlobalWomen’sHealth,March27,2025,Volume
6;ThaísAlquezarFaccaetal.,“Whyispreeclampsiastillanimportantcauseofmaternalmortalityworldwide?,”RevistaBrasileiradeGinecologiaeObstetrícia,October2020,Volume42,Number9.
11JussaraMayrinkandZilmaSilveiraNogueiraRei,“Pre-eclampsiainlow-andmiddle-incomesettings:Whatarethebarrierstoimprovingperinataloutcomesandevidence-basedrecommendations?,”InternationalJournalofGynecology&Obstetrics,
January2024.
12“Pre-eclampsia,”WorldHealthOrganizationfactsheet,October6,2026.
13GenomicsandPrecisionHealthBlog,“Preeclampsia,genomicsandpublichealth,”blogentrybyEricaL.DawsonandMuinJ.Khoury,CentersforDiseaseControlandPrevention(CDC),October25,2022.
14TiffanyShihetal.,“TherisingburdenofpreeclampsiaintheUnitedStatesimpactsbothmaternalandchildhealth,”AmericanJournalofPerinatology,March2016,Volume33,Number4.
15“Answerstoourmostfrequentlyaskedquestions,”PreeclampsiaFoundation,updatedMarch4,2025;“DatafromthePregnancyMortalitySurveillanceSystem,”CentersforDiseaseControlandPrevention(CDC),December18,2025(figureisrelatedtoHDPsandpotentiallyoverstated).
16RolvSkjaervenetal.,“Recurrenceofpre-eclampsiaacrossgenerations:Exploringfetalandmaternalgeneticcomponentsinapopulationbasedcohort,”BMJ,October15,2005,Volume331,Number7521.
17“Preeclampsiaandpregnancy,”AmericanCollegeofObstetriciansandGynecologists(ACOG)women’shealthinfographic,accessedSeptember2026.
18MariamK.Ayyash,RodneyMcLarenJr.,andMajidShaman,“TrendsinpreeclampsiariskfactorsintheUSfrom2010to2021,”JAMA,June10,2024,Volume332,Number2.
19MariaKariori,VasilikiKatsi,andCostasTsioufis,“Latevs.earlypreeclampsia,”InternationalJournalofMolecularSciences,November15,2025,Volume6,Number22.
Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS5
problemswithhowtheplacentadevelops.Inahealthypregnancy,thebloodvessels
supplyingtheplacentawidentoprovideenoughblood,nutrients,andoxygentosupportthegrowingbaby.Inearly-onsetpreeclampsia,thisprocessmaynothappennormally.Emergingscientificresearchpointstoseveralbiologicalmechanisms,includingabnormaltrophoblastinvasionandreduceddevelopmentofuterinespiralarteries.20Early-onsetpreeclampsiacanhaveseriousconsequencesforbothmotherandbaby.Forthemother,itcanleadto
problemswithmajororgans,aseriouscomplicationknownasHELLPsyndrome,orearlyseparationoftheplacentafromthewomb.Forthebaby,reducedbloodflowthroughtheplacentacanrestrictgrowthandrequireearlydeliveryforthebaby.21Babiesbornvery
prematurelyaremorelikelytorequirecareinaneonatalintensivecareunit.
—Late-onsetpreeclampsiadevelopslaterinpregnancyandismorecommoninwomenwith
certainriskfactors,includinglong-termhighbloodpressure,ahigherbodyweight,older
maternalage,andfirstpregnancies.22Comparedwithearly-onsetpreeclampsia,itismore
oftenlinkedtothemother’sunderlyingheart,bloodvessel,andmetabolichealth,although
bothearly-andlate-onsetpreeclampsiasharemanyofthesamebiologicalfeatures.23Late-onsetpreeclampsiacanincreasetheriskofcomplicationsaroundthetimeofdeliveryandisalsolinkedtoanincreasedriskofheartandkidneyproblemslaterinlife.24Becauseit
developslaterinpregnancy,deliverycanoftentakeplaceatornearfullterm,whichreducessomeoftheriskstothebabyassociatedwithbeingbornprematurely.
—Postpartumpreeclampsiapresentsafterdeliveryandisgenerallydefinedasnew-onset
preeclampsiafrom48hoursthroughsixweekspostpartum.Mostdelayedpresentations
occurwithinthefirstseventotendaysofdelivery.25Giventhatsymptomsoftendevelop
afterhospitaldischarge,postpartumpreeclampsiaisoftenundiagnoseduntiltheconditionbecomessevere,increasingtheriskofstroke,seizures,andbraininjury.Postpartum
preeclampsiamayoccurdenovoafterapregnancywithouthypertensionorfollowingantepartumhypertensivedisease.Itspathophysiologyisnotfullyunderstood.26
Theeffectsofpreeclampsiaalsoreachfarbeyondpregnancy,shapingawoman’shearthealthfortherestofherlife.Studiesoncardiovascularriskfindthatpreeclampsiaisassociatedwithafourfoldincreaseinriskofheartfailureandadoublingoftheriskofcoronaryheartdisease,
stroke,andmortalityduetocardiovasculardisease.Preeclampsiaisalsoassociatedwithan
increasedriskofchronichypertension,venousthromboembolism,andotherconditions.27This
researchpointstotheimportanceofpreeclampsiaasnotonlyanacutepregnancycomplicationbutalsoanimportantmarkeroflifelonghealthrisk.
20BertholdHuppertz,“Thecriticalroleofabnormaltrophoblastdevelopmentintheetiologyofpreeclampsia,”CurrentPharmaceuticalBiotechnology,September2018,Volume19,Number10.
21GaetanoSantulli,UrnaKansakar,andFahimehVarzideh,“Epidemiologyandpathophysiologyofpreeclampsia:Newmechanisticinsights,”Hypertension,May2025,Volume82,Number5.
22“Answerstoourmostfrequentlyaskedquestions,”PreeclampsiaFoundation,updatedMarch4,2025.
23AnnaBaylisetal.,“Predictionandpreventionoflate-onsetpre-eclampsia:Asystematicreview,”FrontiersinMedicine,November2024,Volume11.
24ErnawatiErnawatietal.,“Theriskofpersistenthypertensionandchronickidneydiseaseinearly-andlate-onsetpreeclampsia:Areportfromdevelopingcountry,”Cureus,December13,2023,Volume15,Number12.
25“Postpartumpreeclampsia:Symptomsandcauses,”MayoClinic,August17,2021;AlisseHauspurgandArunJeyabalan,
“Postpartumpreeclampsiaoreclampsia:Definingitsplaceandmanagementamongthehypertensivedisordersofpregnancy,”AmericanJournalofObstetrics&Gynecology,February2022,Volume226,Number2S.
26“Postpartumpreeclampsia,”PreeclampsiaFoundation,updatedMarch12,2026.
27PenséeWuetal.,“Preeclampsiaandfuturecardiovascularhealth:Asystematicreviewandmeta-analysis,”Circulation
CardiovascularQualityOutcomes,February2017,Volume10,Number2;LeanneBellamyetal.,“Pre-eclampsiaandriskof
cardiovasculardiseaseandcancerinlaterlife:Systematicreviewandmeta-analysis,”BMJ,November2007,Volume335,
Number7627;LydiaJ.Leonetal.,“PreeclampsiaandcardiovasculardiseaseinalargeUKpregnancycohortoflinkedelectronichealthrecords:ACALIBERstudy,”Circulation,September24,2019,Volume140,Number13;GaiaBianchietal.,“Thedilemmaofchronickidneydiseaseandend-stagekidneydiseasefollowingpre-eclampsia:Aliteraturereviewandmeta-analysis,”
nternationalUrologyandNephrology,December2025,Volume57,Number12.
Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS6
PreeclampsiaoutcomesvarysubstantiallyacrossracialgroupsintheUnitedStates.
Preeclampsiatreatmentexperienceandintensityofcareutilizationdifferbyrace,
socioeconomic,andgeographicalfactors.Notably,Blackwomenareapproximately1.6times
morelikelythanwhitewomentodeveloppreeclampsia,andtheyexperiencehigherratesof
severecomplicationsandpregnancy-relateddeaths.28Thedisparitymaybeevenlargerfor
early-onsetdisease:InoneCaliforniacohort,theprevalenceofpreeclampsiawithdelivery
before32weekswasapproximatelythreetimesashighamongBlackwomenasamongWhitewomen(0.41percentversus0.13percent).29Existingresearchindicatesimportantcontributionsfromsocialdeterminantsofhealth,structuralinequities,differentialexposuretoracismand
chronicstress,andvariationinaccesstoandqualityofcare.30
Theexperienceandintensityofcareamongwomenwithpreeclampsiaalsodiffersaccordingtotypeofinsurance.Around41percentofpregnanciesarecoveredbyMedicaid,andaround52
percentarecoveredbyprivateinsurance(withtheremaining7percentusingself-payorothertypesofcoverage).31OneUSstudyfurtherfoundthatforwomenwithhypertensivedisordersofpregnancyspecifically,54percentarecoveredbyMedicaid,44percentarecoveredbyprivateinsurance,and2percentbyothertypesofcoverage.32Inouranalysisofdeliveriescoveredby
Medicaidversuscommercialinsurance,theaveragegestationalageforwomenwithearly-onsetpreeclampsiawassimilartowomenwithcommercialinsurance(estimated33-34weeks),but
Medicaidmemberswithpreeclampsiahadapproximately3.3to3.5timestheemergency
departmentutilizationandfourtoseventimestheintensivecareunit(ICU)utilizationof
commerciallyinsuredpatients.WithintheMedicaidpopulationanalyzed,Blackwomenwith
preeclampsiahadhigherobservedratesofcesareandelivery,emergencydepartmentutilization,andneonatalintensivecareunit(NICU)admissionthanotherMedicaidmemberswith
preeclampsia.33Thesedifferencesareobservationalandmayreflectvariationinbaselinehealth,socialdeterminantsofhealth,accesstocare,caredelivery,andotherfactors.34
Geographicdisparitiesarealsoevidentintermsofexperienceandutilizationofcare.Inour
analysis,amongMedicaidmemberswithpreeclampsia,womenlivinginruralareashadhigherICUutilizationthantheirurbancounterparts,includingapproximately16percenthigherratesamongwomenwithearly-onsetpreeclampsiaand14percenthigherratesamongwomenwithpostpartumpreeclampsia.35Thesedifferencesmayreflectvariationindiseaseseverity,referralpatterns,accesstocare,caredelivery,andothercontextualfactors;theclaimsdatadonot
establishthemechanismsunderlyingtheobservedgeographicdifferences.
Forallitsprevalenceandseriousness,preeclampsiastillhasnoapprovedtreatmentthat
reversesormeaningfullychangesthediseaseonceithasdeveloped.Managementofindividualsatincreasedriskofpreeclampsiaincludeslow-doseaspirin,thoughuptakeremainslimited.
gyNephrology
28HenriettaO.Fasanyaetal.,“Acriticalreviewontheuseofraceinunderstandingracialdisparitiesinpreeclampsia,”JournalofAppliedLaboratoryMedicine,January12,2021,Volume6,Number1.
29JuanYangetal.“Racial-ethnicdifferencesinmidtrimestermaternalserumlevelsofangiogenicandantiangiogenicfactors,”AmericanJournalofObstetrics&Gynecology,September2016,Volume215,Number3.
30FrancesConti-Ramsden,AntoniodeMarvao,andLucyC.Chappell,“Pregnancydisordersandmaternalconsequences:Ethnicdisparitiesinhypertensivedisordersofpregnancy,”Reproduction,May2025,Volume169,Number6.
31ClaudiaP.ValenzuelaandMichelleJ.K.Osterman,“Characteristicsofmothersbysourceofpaymentforthedelivery:UnitedStates,2021,”NCHSDataBrief,Number468,NationalCenterforHealthStatistics,2023.
32KarenS.Greineretal.,“Associationbetweeninsurancetypeandpregnancyoutcomesinwomendiagnosedwithhypertensivedisordersofpregnancy,”JournalofMaternal-Fetal&NeonatalMedicine,April2020,Volume33,Number8.
33CentersforMedicare&MedicaidServices,100percentMedicaiddata(2021-2024),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeensuppressed).
34MerativeMarketScanCommercialclaimsdata(2018–25);CentersforMedicare&MedicaidServices,100percentMedicaiddata(2021–24),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeen
suppressed).CertaindatausedinthisstudyweresuppliedbyMerativeaspartofoneormoreMerativeMarketScanResearchDatabases.Anyanalysis,interpretation,orconclusionbasedonthesedataissolelythatoftheauthorsandnotMerative.
35CentersforMedicare&MedicaidServices,100percentMedicaiddata(2021–24),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeensuppressed).
Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS7
Exhibit1
Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS8
Managementalongthediseasecourseincludesbutisnotlimitedtoclosematernalandfetal
surveillance,treatmentofseverehypertensionwithantihypertensivemedications,magnesiumsulfateforseizureprophylaxiswhenindicated,andappropriatelytimeddelivery.36TherapeuticcandidatesinpreclinicalandclinicaldevelopmentincludetherapiesthattargetsFLT-1s37(a
proteinproducedlargelybytheplacenta)andthosethatdilatebloodvesselsandreducebloodpressure,38butsubstantialunmetneedremainsfordisease-modifyingtreatmentsandfor
continuedresearchintotheincompletelyunderstoodmechanismsunderlyingpreeclampsia.
Thehumanandeconomiccostsofpreeclampsia
Beyonditssubstantialmortalityandmorbidityburden,preeclampsiaisassociatedwithbillionsofdollarsofhealthcareandsocietalcosts(Exhibit2).Theanalysisinth
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2026年连裤袜行业洞察报告及未来五至十年发展趋势报告
- 2026年其他文化用品零售行业投资规划建议报告及未来五至十年存量博弈与增量突破
- 2026年直流屏培训模拟试题带答案
- 调酒师职业资格考试冲刺练习题库及答案
- 2025年心态修炼《心智成长》考点梳理卷
- 2026年贵州联考模拟试题(含答案)
- 电子商务师职业资格考试历年真题汇编及答案
- 药理学神经系统药物作用机制解析习题及答案
- 旅游市场营销考试旅游产品设计与推广模拟试题及答案
- 药品市场营销与推广历年真题模拟试卷及答案
- 2026年消防安全专题培训(含近期火灾事故案例)
- 国聘社会招聘笔试测评题库
- 纳米多孔材料复合膜:化工分离领域的制备技术与应用探索
- 中医护理技术操作
- 2025版压力性损伤指南解读与临床实践
- 高三化学复习重点教学设计方案
- 2026年保安员证考试题库及答案1套
- 养老机构安全事故处理与报告制度
- 配网工程管理介绍
- 新版中华民族共同体概论课件第八讲共奉中国与中华民族内聚发展(辽宋夏金时期)-2025年版
- 电梯维保合同转移协议书
评论
0/150
提交评论